The main Library (located in the Rockefeller Research Laboratories Building) and the Cyber Library (Zuckerman Research Center) will be closed on Monday, May 25, 2015 in observance of Memorial Day. Regular hours will resume on Tuesday, May 26, 2015 at both of our locations.
Monthly Archives: May 2015
Cyro-EM, HPV Vaccine for Males, New Rules for Genetic Testing and More…
Here are a few highlights of cancer research news that have recently caught my attention:
- Researchers at the NIH have developed an enhanced version of a cryo-electron microscope (also known as cryo-EM) that allows scientists to image a relatively small protein at high resolution. Cyro-EM could become a useful tool in drug development. You can read more about their findings in the journal Science.
- The authors of a statistical study in The BMJ found that routine vaccination of boys against human papillomavirus (HPV) could bring worthwhile benefits for some male populations.
- New findings from a clinical trial sponsored by the National Human Genome Research Institute (NHGRI) offers the clearest picture yet of the prevalence in the U.S. population of mutations in two genes associated with an increased risk of breast cancer. For further details, see ClinicalTrials.gov
SU2C Lung Cancer Dream Team Announced!
Stand Up To Cancer (SU2C) and the American Cancer Society (ACS) recently announced the formation of a $20 million “dream team,” co-led by our very own Jedd Wolchok, chief of the Melanoma and Immunotherapeutics Service.
Funded in part by SU2C, ACS, and Bristol-Myers Squibb, the team has devised a three-pronged approach to focus on KRAS mutant lung cancer which includes: working to define the most effective therapies to target KRAS and critical related biological pathways, targeting the immune system for the treatment of KRAS mutant lung cancers, and integrating targeted therapies with immunotherapies for these lung cancers.
For more information, see the SU2C-ACS Lung Cancer Dream Team: Targeting KRAS Mutant Lung Cancers and other SU2C Scientific Research Teams.